KRAS Mouse Monoclonal Antibody [Clone ID: OTI2C1]
CAT#: TA801672
KRAS mouse monoclonal antibody, clone OTI2C1 (formerly 2C1)
Size: 30 ul
Formulation: Carrier-Free
View other "OTI2C1" antibodies (4)
Need it in bulk or conjugated?
Get a free quote
热销推荐
CNY 1,999.00
CNY 2,700.00
Cited in 1 publication. |
CNY 300.00
CNY 1,430.00
CNY 2,900.00
CNY 6,650.00
CNY 3,080.00
CNY 9,998.00
CNY 3,080.00
Specifications
Product Data | |
Clone Name | OTI2C1 |
Applications | IHC, WB |
Recommend Dilution | IHC 1:100, WB 1:2000 |
Reactivity | Human, Mouse, Rat |
Host | Mouse |
Clonality | Monoclonal |
Immunogen | Full length human recombinant protein of human KRAS (NP_203524) produced in E.coli. |
Formulation | PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide. |
Concentration | 1 mg/ml |
Purification | Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) |
Conjugation | Unconjugated |
Storage Condition | Store at -20°C as received. |
Predicted Protein Size | 21.5 kDa |
Gene Name | KRAS proto-oncogene, GTPase |
Database Link | |
Background | This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. [provided by RefSeq, Jul 2008] |
Synonyms | C-K-RAS; c-Ki-ras2; CFC2; K-RAS2A; K-RAS2B; K-RAS4A; K-RAS4B; KI-RAS; KRAS1; KRAS2; NS; NS3; RALD |
Reference Data | |
Protein Families | Druggable Genome |
Protein Pathways | Acute myeloid leukemia, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Chemokine signaling pathway, Chronic myeloid leukemia, Colorectal cancer, Dorso-ventral axis formation, Endometrial cancer, ErbB signaling pathway, Fc epsilon RI signaling pathway, Gap junction, Glioma, GnRH signaling pathway, Insulin signaling pathway, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Non-small cell lung cancer, Pancreatic cancer, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Regulation of actin cytoskeleton, Renal cell carcinoma, T cell receptor signaling pathway, Thyroid cancer, Tight junction, VEGF signaling pathway |
Citations (1)
The use of this Antibodies has been cited in the following citations: |
---|
Mutation-specific effects of NRAS oncogenes in colorectal cancer cells
,Kuhn, N;Klinger, B;Uhlitz, F;Sieber, A;Rivera, M;Klotz-Noack, K;Fichtner, I;Hoffmann, J;Blüthgen, N;Falk, C;Sers, C;Schäfer, R;,
Advances in Biological Regulation
,PubMed ID 33431353
[KRAS]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
CF801672 | Carrier-free (BSA/glycerol-free) KRAS mouse monoclonal antibody, clone OTI2C1 (formerly 2C1) |
CNY 3,999.00 |
|
TA801672AM | KRAS mouse monoclonal antibody,clone 2C1, Biotinylated |
CNY 3,990.00 |
|
TA801672BM | KRAS mouse monoclonal antibody,clone 2C1, HRP conjugated |
CNY 3,990.00 |
|
TA801672S | KRAS mouse monoclonal antibody, clone OTI2C1 (formerly 2C1) |
CNY 800.00 |